GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52 | -45.3% | 13,594 | -21.9% | 0.00% | – |
Q2 2023 | $95 | -26.9% | 17,395 | -42.4% | 0.00% | – |
Q1 2023 | $130 | +154.9% | 30,186 | +133.8% | 0.00% | – |
Q4 2022 | $51 | -99.5% | 12,913 | +533.0% | 0.00% | – |
Q3 2022 | $11,000 | -35.3% | 2,040 | -19.5% | 0.00% | – |
Q2 2022 | $17,000 | -68.5% | 2,534 | -65.2% | 0.00% | – |
Q1 2022 | $54,000 | – | 7,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |